Clinical Trials Phase I and Phase IIA Congress

"Conference focus on the potential for agency collaboration and a more efficient inspection system"
The mission of the Clinical Trials Phase I & Phase IIA Summit is to provide attendees with the strategies and insight necessary to ensure their early-stage clinical trials are executed on time and within budget while exploring how to leverage innovative approaches to managing clinical trials for all therapeutic areas.

User Reviews

4
10 Aug 2016

Aileen Ward Director at Shionogi Florham Park, USA

would have liked to have spent more time going through some of the checklist and also how to respond to specific inspection questions especially if there is no answer or if something was not done.

Report Helpful Reply

---

Speakers (past edition)

Speaker

Colin Scott

Global Clinical Leader at Bayer HealthCare United States

Follow

Speaker

Ken Chang

Follow

Speaker

Jeannette Dixon

Associate Director, Quality Assurance, GCP-GLP at Daiichi Sankyo, Inc. at...

Follow

Speaker

Federico Feldstein

Vice President, Head of Quality & Compliance at The Janssen...

Follow

Speaker

Noelle Nicolo

Regulatory Inspection and Issue Investigation Manager at GSK at GSK

Follow

Speaker

Dawn Niccum

Quality Manager at Endocyte at Endocyte United States

Follow

Speaker

Karen Roycroft

Associate Director, Clinical Quality Management at Otsuka America Pharmaceutical, Inc...

Follow

Follow
More Speakers